Vor Biopharma (VOR) director receives 53,283 stock options at $14.09 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vor Biopharma director Daniella Beckman received a grant of 53,283 stock options to buy Vor Biopharma common stock at an exercise price of $14.09 per share. These options were awarded as compensation and are held directly.
According to the vesting schedule, one thirty-sixth of the options will vest and become exercisable on July 11, 2026, with additional installments vesting monthly thereafter, as long as she continues to serve the company. After this grant, she holds stock options covering 53,283 underlying shares, which will expire on June 10, 2036 if not exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Beckman Daniella
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 53,283 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 53,283 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 53,283 options
Exercise price: $14.09 per share
Underlying shares: 53,283 shares
+3 more
6 metrics
Stock options granted
53,283 options
Grant to director on June 11, 2026
Exercise price
$14.09 per share
Strike price for the 53,283 options
Underlying shares
53,283 shares
Common stock underlying the option grant
Post-transaction option holdings
53,283 options
Total derivative holdings following grant
Vesting start date
July 11, 2026
First vesting date for one thirty-sixth of options
Expiration date
June 10, 2036
Option expiration if not exercised
Key Terms
Stock option (right to buy), exercise price, vesting, expiration date
4 terms
Stock option (right to buy) financial
"security_title: Stock option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 14.0900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option shall vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-10T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did Vor Biopharma (VOR) report for Daniella Beckman?
Vor Biopharma reported that director Daniella Beckman received a grant of 53,283 stock options. These options give her the right to buy common shares at an exercise price of $14.09 per share, subject to a multi-year vesting schedule tied to continued service.
What is the size and exercise price of Daniella Beckman’s Vor Biopharma (VOR) stock option grant?
The grant covers 53,283 stock options with an exercise price of $14.09 per share. This means she can buy up to 53,283 Vor Biopharma common shares at that fixed price once the options vest and become exercisable over time.
How do Daniella Beckman’s Vor Biopharma (VOR) options vest over time?
One thirty-sixth of the 53,283 options will vest on July 11, 2026, with additional installments vesting each month afterward. Vesting continues only if she remains in service, creating a long-term alignment between her compensation and ongoing involvement with Vor Biopharma.
When do Daniella Beckman’s Vor Biopharma (VOR) stock options expire?
The stock options are scheduled to expire on June 10, 2036. If they are not exercised by that date, they will lapse. This expiration date sets a long-term window during which vested options can potentially be used to purchase Vor Biopharma common shares.
How many Vor Biopharma (VOR) options does Daniella Beckman hold after this transaction?
Following this grant, Daniella Beckman holds stock options covering 53,283 underlying shares of Vor Biopharma common stock. The Form 4 indicates these options are held directly and that this award represents her reported derivative position in the company after the transaction.